Biofrontera Inc.
BFRI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6,013 | $4,283 | $19,385 | $128,628 |
| - Cash | $5,905 | $1,343 | $17,208 | $24,545 |
| + Debt | $4,922 | $5,399 | $1,346 | $0 |
| Enterprise Value | $5,030 | $8,339 | $3,523 | $104,083 |
| Revenue | $37,303 | $34,071 | $28,674 | $24,100 |
| % Growth | 9.5% | 18.8% | 19% | – |
| Gross Profit | $18,696 | $16,627 | $13,489 | $11,358 |
| % Margin | 50.1% | 48.8% | 47% | 47.1% |
| EBITDA | -$14,441 | -$18,453 | $934 | -$36,757 |
| % Margin | -38.7% | -54.2% | 3.3% | -152.5% |
| Net Income | -$17,759 | -$20,131 | -$640 | -$37,713 |
| % Margin | -47.6% | -59.1% | -2.2% | -156.5% |
| EPS Diluted | -3.22 | -13.02 | -0.61 | -44.1 |
| % Growth | 75.3% | -2,034.4% | 98.6% | – |
| Operating Cash Flow | -$10,270 | -$24,895 | -$16,199 | -$26,715 |
| Capital Expenditures | -$60 | -$5 | -$38 | -$11 |
| Free Cash Flow | -$10,330 | -$24,900 | -$16,237 | -$26,726 |